The sudden death of Shefali Jariwala, best known for her iconic song Kaanta Laga, due to cardiac arrest, has again shaken the nation. Her case follows other shocking deaths of young celebrities like Sidharth Shukla and Puneeth Rajkumar, all of whom appeared healthy and fit. These tragic events have sparked public concern and brought fresh attention to the rising trend of heart attacks among young Indians, shining a spotlight on India’s evolving diagnostics sector.
⚠️ Young, Fit, and at Risk: What’s Happening?
Heart attacks, once considered a disease of the elderly, are now claiming the lives of people under 50, including those who are active, non-smokers, and seemingly healthy. The reasons are complex — stress, sedentary lifestyles, poor dietary habits, and possible post-COVID complications — but the message is clear: proactive health screening is no longer optional.
This behavioral shift has fueled the meteoric rise of India’s diagnostics sector, which is transforming from a fragmented service into a tech-driven, structured industry.
📈 The Rise of Diagnostics in India
India’s diagnostics market, valued at $25 billion, is among the fastest-growing healthcare segments in the country. According to reports, the sector is projected to grow at a CAGR of 14% till FY2028. This rapid growth has been powered by:
- Post-COVID awareness of preventive testing
- Rising cases of non-communicable diseases (NCDs) like heart disease, diabetes, hypertension, and cancer
- A growing demand for home-based testing and AI-led radiology
- Entry of large players like Amazon, which brings convenience and competitive pricing
🦠 COVID-19: The Catalyst for Diagnostics Growth
The pandemic changed the way Indians think about health. Diagnostic labs, once working quietly in the background, became central to COVID management. This triggered:
- A 50%+ jump in revenue for major diagnostic players between FY20–FY22
- Widespread adoption of preventive screenings
- Investments in infrastructure, digital tools, and mergers to expand reach from regional to national level
Post-pandemic, the trend of routine cardiac and immune health testing continues, with many opting for ECGs, lipid profiles, and inflammatory marker panels, especially after reports of post-COVID heart-related complications.
🏥 Diagnostics in Small Towns and Non-Metro Cities
Diagnostics growth isn’t limited to big cities. Tier-2 and Tier-3 towns are growing at 20–25% annually, driven by:
- Better health awareness
- Rising incomes and health insurance coverage
- Expansion efforts by organized players like Dr Lal PathLabs, Metropolis, Thyrocare, and SRL
- Local partnerships and mobile sample collection centers
For instance, Suraksha Diagnostics recently announced an investment of ₹200 crore to open 20 advanced imaging centers across eastern India, focusing on affordability and access.
🛒 Amazon Enters the Scene
In a game-changing move, Amazon India launched its diagnostics services in partnership with Orange Health Labs. Now active in six cities and 450+ PIN codes, it offers:
- 800+ tests
- Home sample collection in under 60 minutes
- Reports within six hours
This entry has disrupted the market, with shares of existing giants like Dr Lal PathLabs and Metropolis falling slightly, indicating fears of pricing pressure and tech-led competition.
🏛️ Government Support & Insurance Push
The Ayushman Bharat initiative and state-level PPP models, like the Punjab government’s tie-up for CT/MRI centers, are boosting diagnostic access in public healthcare. Moreover, health insurance plans now cover preventive diagnostics and annual health checks, reducing out-of-pocket costs and improving uptake.
🔬 Structural Shifts in the Industry
India’s diagnostics market is still largely fragmented:
- 48% of the market is held by unorganized labs
- 37% by hospital-based labs
- Only 15% is currently with organized diagnostic chains — but this number is rising fast
This transition from unorganized standalone labs to quality-driven national chains is reshaping the sector, bringing better standards, faster service, and patient trust.
🔍 What Lies Ahead for Diagnostics?
According to PhillipCapital:
- The radiology segment will grow from $7.1 billion in FY25 to $13.5 billion by FY30
- Tech integration, like AI in imaging, genomic testing, and personalized diagnostics, will drive innovation
However, the industry must overcome:
- Pricing pressure from new entrants
- Quality control issues in smaller labs
- Lack of standardization and regulation
🩺 What This Means for Healthcare Professionals
For doctors, hospitals, and healthcare entrepreneurs, this is the moment to:
- Embrace preventive healthcare as a long-term practice model
- Partner with credible diagnostics providers
- Stay updated on new tech tools in radiology and pathology
- Educate patients on the importance of routine testing, especially for heart health
💡 The Doctorpreneur Academy’s Perspective
At The Doctorpreneur Academy, we help healthcare professionals lead in a changing world, and the diagnostics boom is one of the most defining shifts today.
We support:
- Doctors exploring partnerships in diagnostics
- Entrepreneurs entering tier-2 and tier-3 diagnostic markets
- Clinics adopting home testing models
- Medical professionals embracing digital and AI-led diagnostics
✅ Final Thoughts
The rising cases of sudden cardiac deaths in young Indians are alarming, but they are also prompting a positive shift — more people are investing in preventive healthcare and routine diagnostics.
India’s diagnostics sector is no longer behind the scenes. It is now front and center, offering a bridge between early detection and long-term wellness. As organized players grow, tech integrates deeper, and consumer demand rises, diagnostics is becoming the heartbeat of India’s new-age healthcare ecosystem.
👉 Want to stay ahead of healthcare trends, digital innovation, and professional growth?
Explore resources, strategies, and insights at The Doctorpreneur Academy — where medicine meets modern leadership.
👉 To register for our next masterclass, please click here https://linktr.ee/docpreneur
